Citation Impact

Citing Papers

Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer
1999 Standout
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Cellular and molecular aspects of neoplastic progression in the mammary gland
1988
The advantages and disadvantages of being polyploid
2005 Standout
Indicators of Prognosis in Node-Negative Breast Cancer
1990
pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up
1991 Standout
Pseudomalignant spindle cell proliferations of the urinary bladder
1994
Phase III randomized study to compare interferon alfa-2a in combination with fluorouracil versus fluorouracil alone in patients with advanced colorectal cancer.
1996
Histopathologic and Cytochemical Characteristics of Interval Breast Carcinomas from the Stockholm Mammography Screening Project
1992
Estrogen Receptor Breast Cancer Phenotypes in the Surveillance, Epidemiology, and End Results Database
2002
Inflammatory myofibroblastic tumours: where are we now?
2007 Standout
Breast Density as a Predictor of Mammographic Detection: Comparison of Interval- and Screen-Detected Cancers
2000 Standout
Prognostic value of DNA cytometry in 281 premenopausal patients with lymph node negative breast carcinoma randomized in a control trial
2000
Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow Cytometry
1989
Binding of pRB to the PHD Protein RBP2 Promotes Cellular Differentiation
2005 StandoutNobel
Pathological prognostic factors in breast cancer
1999 Standout
Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro
2000 Standout
Automated breast tumor diagnosis and grading based on wavelet chromatin texture description
1998
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
5-Fluorouracil: mechanisms of action and clinical strategies
2003 Standout
Histopathological Image Analysis: A Review
2009 Standout
Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker
2000 Standout
Cancer as an evolutionary and ecological process
2006 Standout
DNA Flow Cytometry Does Not Predict 5- or 10-Year Recurrence Rates for T1-2 Node-Negative Breast Cancer
2000
Histological Grading of Breast Cancer
1990
DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis
1992
Prognostic value of nuclear DNA content in medullary thyroid carcinoma
1985
Tumor DNA Content in the Prognosis of Colorectal Carcinoma
1986 Standout
Characterization of topoisomerase II? gene amplification and deletion in breast cancer
1999
Flow cytometry in primary breast carcinomas. Prognostic impact of proliferative activity
2000
Multiple centrosomes arise from tetraploidy checkpoint failure and mitotic centrosome clusters in p53 and RB pocket protein-compromised cells
2002
Progression to Malignancy in the Polyoma Middle T Oncoprotein Mouse Breast Cancer Model Provides a Reliable Model for Human Diseases
2003 Standout
Quality indicators for colonoscopy
2014 Standout
Role of HER2 gene overexpression in breast carcinoma
2000
Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis.
1995
Altered Expression of the Retinoblastoma Tumor-Suppressor Gene in Leukemic Cell Lines Inhibits Induction of Differentiation But Not G1-Accumulation
1997
Receptors for Purines and Pyrimidines
2012 Standout
Characterization of topoisomerase II alpha gene amplification and deletion in breast cancer.
1999
Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis
2006 Standout
Bisphenol-A and the Great Divide: A Review of Controversies in the Field of Endocrine Disruption
2009 Standout
Cloned human teratoma cells differentiate into neuron-like cells and other cell types in retinoic acid
1984
Flow‐Cytometric DNA analysis in primary breast carcinomas and clinicopthological correlations
1984
UDP acts as a growth factor for vascular smooth muscle cells by activation of P2Y6receptors
2002
Inflammation and Cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation
2004 Standout

Works of Anders Fallenius being referenced

Prognostic significance of immunohistochemical c-erbB-2 proto-oncogene expression and nuclear DNA content in human breast cancer.
1992
Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S‐Phase fraction by flow cytometry
1992
Prognostic significance of dna measurements in 409 consecutive breast cancer patients
1988
Prognostic value of nuclear DNA content in breast cancer in relation to tumor size, nodal status, and estrogen receptor content
1989
Predictive value of nuclear DNA content in breast cancer in relation to clinical and morphologic factors. A retrospective study of 227 consecutive cases
1988
Cytophotometrical and biochemical characterization of nonpalpable, mammographically detected mammary adenocarcinomas
1984
Cytochemical changes in the nucleus during tumour development
1983
Progression of mammary adenocarcinomas as reflected by nuclear DNA content
1984
Two randomised phase II trials of intermittent intravenous versus subcutaneous alpha-2 interferon alone (Trial 1) and in combination with 5-fluorouracil (Trial 2) in advanced colorectal cancer
1987
Cytochemical classification of nonpalpable breast carcinoma.
1983
Prognostic Significance of Nuclear DNA Analysis in Histological Sections in Mammary Carcinoma
1986
Comparison between slide and flow cytophotometric DNA measurements in breast tumors.
1987
Rankless by CCL
2026